Bone turnover decreases and bone structure improves during treatment with weekly high-dose methylprednisolone for 12 weeks in Graves’ orbitopathy
Crossref DOI link: https://doi.org/10.1007/s12020-023-03494-5
Published Online: 2023-09-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Harsløf, Torben http://orcid.org/0000-0002-8581-3523
Hikmet, Rawan
Ebbehøj, Eva
Langdahl, Bente
Text and Data Mining valid from 2023-09-07
Version of Record valid from 2023-09-07
Article History
Received: 24 May 2023
Accepted: 11 August 2023
First Online: 7 September 2023
Compliance with ethical standards
:
: The authors declare no competing interests.